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ABSTRACT: Fluoride has been overlooked as a target in the development of
synthetic anion transporters despite natural ﬂuoride transport channels being recently
discovered. In this paper we report the direct measurement of ﬂuoride transport across
lipid bilayers facilitated by a series of strapped calix[4]pyrroles and show that these
compounds facilitate transport via an electrogenic mechanism (determined using
valinomycin and monensin coupled transport assays and an additional osmotic
response assay). An HPTS transport assay was used to quantify this electrogenic
process and assess the interference of naturally occurring fatty acids with the transport
process and Cl− over H+/OH− transport selectivity.
■ INTRODUCTION
Transmembrane ion transport facilitated by protein channels
is essential in maintaining ion homeostasis.1 In the past decade,
the development of synthetic anion transporters has attracted
much attention, with a variety of small molecules being developed
to facilitate the transport of biologically relevant anions such as
chloride,2−12 bicarbonate,13−16 and sulfate.17 These compounds
may ﬁnd future application in the treatment of diseases caused
by faulty ion channels, such as cystic ﬁbrosis.1
Fluoride is used as an additive in water and oral hygiene
products18 and is found at levels of 10−100 μM in the aqueous
environment.19 Exposure to high levels of ﬂuoride (above
1.5 mg/L20,21) can be detrimental to health, leading to ﬂuorosis,
which aﬀects teeth and bones.22 To the best of our knowledge,
no synthetic compound has been shown to facilitate ﬂuoride
transport across lipid bilayers. Fluoride is small, hard, and basic,
with a higher hydration energy23 than chloride and bicarbonate,
making ﬂuoride complexation in water a challenging problem.
In organic environments, deprotonation of anion receptors
by ﬂuoride,24−30 driven by the formation of biﬂuoride, can be
a competing process to ﬂuoride complexation. The use of Lewis
acidic metal centers by Gabbai ̈ and co-workers in ﬂuoride
sensors has allowed ﬂuoride detection in water below the
maximum contaminant level (4 ppm) set by the Environment
Protection Agency.31−33 Additionally, some Lewis acid-based
compounds have been found to act as ﬂuoride anionophores
across artiﬁcial PVC-DOS membranes within the ﬁeld of ion-
selective electrodes (ISEs),34 and ﬂuoride sensing using boronic
acid derivatives has been shown to be a successful strategy by
Shinkai, James, and others.35−37 In early work by Sessler and co-
workers, ﬂuoride transport through a liquid membrane system
was facilitated by a protonated sapphyrin within a U-tube.38 The
transmembrane exchange of ﬂuoride facilitated by the protein
capnophorin in red blood cells has also been investigated utiliz-
ing 19F NMR techniques.39 Other interesting work by Matile40
and Berezin41 has shown promising indirect results for ﬂuoride
as a potential target for lipid bilayer transport and provides a
strong precedent that this transport is achievable.
Over the past 4 years, seminal work by Miller et al. has
revealed the existence of two naturally occurring, phylo-
genetically unrelated families of F− exporter anion channels,
CLCF F−/H+ antiporters,19,42−44 and small membrane channel
“Fluc” proteins,45−48 the former found solely in bacterial cells,
while the Fluc proteins are widespread among unicellular
organisms as well as eukaryotes. These channels possess strong
selectivity for F− over Cl−, and crystal structures of a Fluc
channel from Bordetella pertussis reveal a surprising “double-
barreled” channel architecture in which selectivity is achieved
by the small bore of the channel.48
These channels reduce bacterial ﬂuoride toxicity, which occurs
due to the weak acid accumulation eﬀect,47 by exporting ﬂuoride
to maintain the cytoplasmic ﬂuoride concentration below
enzyme inhibitory levels.
We therefore decided to investigate whether it was possible
to facilitate the transport of ﬂuoride through lipid bilayers using
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small-molecule anion carriers and determine whether such
transport could be achieved selectively over chloride transport.
Herein we report the ﬁrst instance of directly measured small-
molecule transmembrane ﬂuoride transport with a series of
strapped calix[4]pyrroles 2−4.49 We have recently found that
anion transporters can bind and facilitate the ﬂip-ﬂop of
fatty acids across lipid bilayer membranes.50 We therefore also
decided to investigate the interaction of these compounds both
with acetate in solution and with fatty acids in lipid bilayers.
■ RESULTS AND DISCUSSION
We investigated whether strapped calix[4]pyrroles could be
used to mediate ﬂuoride transport. Calix[4]pyrroles are less
acidic than the urea and thiourea transporter motifs that our
group, and others, have recently explored and are therefore
less likely to be deprotonated within the lipid bilayer.23
Calix[4]pyrroles 1−4 (Figure 1) were synthesized following
literature procedures,49 and their F− binding aﬃnity was
evaluated using 1H NMR titration methods and isothermal
titration calorimetry (ITC). A variety of anion transport assays
were employed to fully characterize the ﬂuoride transport
processes facilitated by 1−4.51
Anion Binding Studies and Solid-State Analysis.
Proton NMR titration studies in DMSO-d6/0.5% H2O with
tetrabutylammonium ﬂuoride (TBAF) and compounds 1−4
resulted in slow exchange of the ﬂuoride complex and the free
calix[4]pyrrole on the NMR time scale. A downﬁeld shift of
the pyrrole NH resonances and the triazole CH resonance and
coupling of the NH resonance to the 19F nucleus of the ﬂuoride
anion were observed, which are usually indicative of strong
hydrogen bonding. Slow exchange was observed previously with
tetrabutylammonium chloride (TBACl) and compounds 2−4.49
Slow exchange was also observed upon addition of tetrabutyl-
ammonium acetate with compounds 2−4, and a stability
constant of 6060 M−1 was derived from global ﬁtting analysis
using bindﬁt52,53 with compound 1 in DMSO-d6/0.5% H2O.
An interesting splitting eﬀect for the pyrrole NH was observed
for the titration with 2 with acetate, suggesting two environ-
ments, which we attribute to the OAc− not binding symmetri-
cally within the smaller cavity of compound 2. NMR spectra and
species ratio plots can be found in the Supporting Information.
Quantiﬁcation of the binding aﬃnity was performed using ITC
in acetonitrile. The results, summarized in Table 1, show that
compounds 1−4 exhibit exothermic complexation of both salts
with slightly unfavorable entropic contributions for all, except
1 and 4, with tetraethylammonium ﬂuoride. Receptors 1−4 bind
strongly to ﬂuoride, with Ka ≥ 106 M−1 with no indications of
deprotonation, supporting their suitability for ﬂuoride transport.
This strong binding for 1−4 is similar to that seen for
tetraethylammonium chloride binding, with previous literatureFigure 1. Structures of the calix[4]pyrroles 1−4 used in this study.
Table 1. Overview of the Association Constants and Thermodynamic State Functions for the 1:1 Complexation of
Tetraethylammonium Salts with 1−4 As Measured in Acetonitrile by ITC at 303 K
ﬂuoride acetate
receptor Ka (M
−1) ΔG (kJ mol−1) ΔH (kJ mol−1) TΔS (kJ mol−1) Ka (M−1) ΔG (kJ mol−1) ΔH (kJ mol−1) TΔS (kJ mol−1)
1 3.5 × 106 −38.0 −30.1 7.9 5.2 × 105 −33.2 −45.3 −12.1
2 1.3 × 106 −35.5 −44.5 −9.0 1.3 × 105 −29.7 −41.4 −11.7
3 1.1 × 107 −40.8 −44.6 −3.8 1.7 × 106 −36.3 −51.1 −14.8
4 1.9 × 107 −42.2 −34.5 7.7 1.2 × 106 −35.4 −42.7 −7.3
Figure 2. (a) Single-crystal X-ray structure of 2·TBAF complex (TBA not shown for clarity). (b) Single-crystal X-ray structure of 2·TBACl complex
(TBA not shown for clarity). (c) Single-crystal X-ray structure of 3·CsF complex (ethanol solvent not shown for clarity). N···F, N···Cl, C···F, and
C···Cl distances for all structures are displayed as red dashed lines, with measurements (Å) in black. Full crystallographic data can be found in the
Supporting Information.
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reporting a Ka range of 10
5−106 M−1 in acetonitrile.49,54 Acetate
binding was slightly weaker, with a Ka range of 10
5−106 M−1
(Table 1). As expected, acetate binding was stronger for 1, 3,
and 4 compared to 2, which may be due to the short strap
constricting the binding cavity size. ITC binding isotherms can
be found in the Supporting Information.
Solid-state structures of 2 complexed with F− and Cl−
(Figure 2a,b) show the anion bound within the strapped
cavity, with shorter N···F distances of 2.747(3)−2.787(3) Å
observed compared to N···Cl (3.247(2)−3.271(2) Å) and an
additional stabilizing eﬀect from the triazole CH for 2·TBAF.
Hence, the ﬂuoride appears to be bound more strongly, at least
Figure 3. (a) Summary of the cationophore-coupled ﬂuoride and chloride eﬄux ISE assays, including the structures of valinomycin and monensin.
All ISE assays were performed with POPC LUVs (200 nm) loaded with KF or KCl (300 mM) and suspended in KGlc (300 mM) at pH 7.2, and the
anion eﬄux was monitored using a ﬂuoride- or chloride-selective electrode. (i) Schematic showing net KF eﬄux from two electrogenic processes,
K+ transport and F− transport, facilitated by valinomycin (1.0 μM, 0.1 mol%) and the calixpyrrole (20 μM, 2.0 mol%), respectively. (ii) Schematic
showing net KCl eﬄux from two electrogenic processes, K+ transport and Cl− transport, facilitated by valinomycin (1.0 μM, 0.1 mol%) and the
calixpyrrole (20 μM, 2.0 mol%), respectively. (iii) Schematic showing KF eﬄux caused by simple diﬀusion of HF coupled with K+/H+ antiport
facilitated by monensin (1.0 μM, 0.1 mol%). (iv) Schematic showing formal KCl eﬄux from two electroneutral processes, K+/H+ antiport and
H+/Cl− symport (OH−/Cl− antiport), by monensin (1.0 μM, 0.1 mol%) and the calixpyrrole (20 μM, 2.0 mol%), respectively. (b) Fluoride eﬄux
observed in the assay (a)-(i) facilitated by 1−4. (c) Chloride eﬄux observed in the assay (a)-(ii) facilitated by 1−4. (d) Fluoride eﬄux observed in
the assay (a)-(iii) caused by the K+/H+ antiport facilitated by monensin. (e) Chloride eﬄux observed in the assay (a)-(iv) facilitated by 4 in the
presence of valinomycin and monensin.
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in the solid state. Figure 2c shows the crystal structure of the
cesium ﬂuoride complex of 3, which is similar to the cesium
chloride complex of the parent macrocycle 1,55 with N···F
distances of 2.775(3)−2.828(4) Å and the cesium sitting in the
calixpyrrole cup-shaped cavity formed by the pyrrole rings.
Anion Transport Studies. The ﬂuoride transport activities
of 1−4 were probed using the vesicle-based ISE assay shown in
Figure 3a(i), which was adapted from the literature.44 Large
unilamellar vesicles (LUVs, 200 nm) composed of 1-palmitoyl-
2-oleoyl-sn-glycero-3-phosphocholine (POPC) were loaded
with KF (300 mM) and suspended in potassium gluconate
(KGlc, 300 mM). All solutions were buﬀered to pH 7.2 with
HEPES (10 mM). Transport was initiated by addition of
valinomycin (Vln), followed by the anionophore 30 s later, and
ﬂuoride eﬄux was measured directly using a ﬂuoride selective
electrode. The driving force in this assay is the large ﬂuoride
gradient. In the absence of valinomycin and an anion trans-
porter, ﬂuoride eﬄux is minimal. Fluoride eﬄux can occur only
in the presence of valinomycin, which allows for the dissipation
of the membrane potential that would occur if the ﬂuoride
transport facilitated by an anion transporter occurred alone.42,51
The results for this assay are shown in Figure 3b. Compounds
2−4 were all found to function as ﬂuoride transporters at
20 μM, 2 mol% (with respect to lipid concentration), with 3
being the most eﬀective, while compound 1 showed no trans-
port activity under these conditions. Following this encouraging
result, the assay was repeated in the absence of Vln with POPC
vesicles loaded with MF (M = Na, K, Cs, Rb) to assess the
group 1 metal cation co-transport abilities of 1−4.
Previous studies have shown that calix[4]pyrroles have high
aﬃnity for cesium halides. Small halide ions have been shown
to organize 1 into a cone conformation, providing an electron-
rich cup which binds the large charge-diﬀuse Cs+ cation.55,56
Earlier research conﬁrms that 1 can selectively co-transport
the CsCl ion pairs across lipid bilayers, and addition of a variety
of straps can both enhance the aﬃnity of the receptor for
chloride and encapsulate the anion binding site. This allows
the transporter to facilitate chloride uniport and hence permits
processes such as Cl−/NO3
− antiport to occur in addition to
cesium chloride co-transport.49,57 Under the conditions of
the transport experiment, all the receptors function as CsF
co-transporters (and not NaF, KF, RbF), with compound 1
outperforming compounds 2−4. These results can be found in
the Supporting Information.
To establish the selectivity for F− over Cl−, a series of dose−
response experiments were performed using the Vln-coupled
assay used previously. For chloride, the POPC vesicles were
loaded with KCl (300 mM) and the eﬄux was measured
using a chloride-selective electrode, as seen in Figure 3a(ii). Hill
analyses58 were performed to give the eﬀective concentration to
achieve 50% anion eﬄux (EC50) at 270 s, and the results are
shown in Table 2. The ﬂuoride selectivity factor, SF, calculated
by taking the ratio of EC50(Cl
−)/EC50(F
−), shows a preference
for ﬂuoride transport (SF > 1.0) for the shorter strapped
receptors 2 and 3 compared to 4, which displayed marginal
chloride selectivity. This was attributed to the larger size of the
binding cavity in 4. These results also lead us to suggest that
2−4 can function as electrogenic ﬂuoride transporters due to
their ability to couple to K+ transport, facilitated by electrogenic
valinomycin. There is a net transfer of charge across the
membrane by valinomycin-enabled potassium transport, thus
dissipating the membrane potential61 that is caused by ﬂuo-
ride transport by 2−4 to give overall KF eﬄux. To conﬁrm
this mechanism, coupling to monensin (Mon), an electroneutral
cationophore, was investigated. Mon facilitates K+/H+ antiport
and causes no transfer of net charge, but dissipates a pH
gradient.62 If a receptor could facilitate H+/F− co-transport
(or F−/OH− antiport), it would couple to Mon, preventing the
buildup of a pH gradient and once again giving overall KF eﬄux.
However, due to the electroneutral nature of Mon, even in the
absence of an anionophore, F− is permeabilized in the form of
HF, and 100% eﬄux is observed within the experimental time
scale (Figure 3a(iii) and d). Mon coupled experiments were
therefore performed using KCl-loaded vesicles (Figure 3a(iv))
and the results compared to the Vln-coupled Cl− assay.
Compounds 2−4 show no response when coupled to Mon,
as illustrated in Figure 3e for 4 (the data for the other com-
pounds are shown in the Supporting Information). These results
support the hypothesis that 2−4 function via an electrogenic
transport mechanism. An osmotic response assay was performed
to provide further evidence in support of the electrogenic
transport mechanism, and to provide supporting evidence
to rule out H+ or OH− transport. Vln and 1−4-facilitated KF
(300 mM) eﬄux was monitored from POPC vesicles suspended
in KGlc (300 mM). Due to the formation of an osmotic gradient,
water eﬄux follows the KF eﬄux, causing vesicle shrinkage.
This increases the amount of 90° light scattering, which can be
monitored. Receptors 2−4 showed an increase in light scattering
and therefore a positive response for Vln-coupled KF eﬄux,
which can be seen in Figure 4a. To rule out H+ and OH−
transport, which could cause background HF transport, a control
assay was performed with KOAc-loaded vesicles. The acetate ion
alone is membrane impermeable (unless transported); however,
protonation of acetate resulting from transport of H+ or OH−,
potentially facilitated by 2−4, may form membrane-permeable
acetic acid. Figure 4b shows the results for 3 and 4. No
permeabilization of acetate was seen for 1−3, which is evidence
in support of the absence of H+ and OH− transport. Conversely,
4 shows a positive result for the acetate control assay, which
was attributed to the larger strapped cavity allowing for acetate
binding and transport, and not H+ or OH− transport. This is
supported by the strong aﬃnity of this receptor for OAc− from
the ITC results and the fact the transport mechanism cannot
couple to monensin.
Additionally, we quantiﬁed the Cl− > H+/OH− selectivity of
the strapped calixpyrroles using a modiﬁed NMDG-Cl assay,10,51
which involves the use of gramicidin D (Gra), a naturally
occurring proton channel, and oleic acid (OA), a naturally
occurring monounsaturated omega-9 fatty acid. POPC LUVs
(200 nm) were loaded with 8-hydroxypyrene-1,3,6-trisulfonic acid
(HPTS, a pH-sensitive dye, 1 mM) and N-methyl-D-glucamine
Table 2. Transport Activity from the Fluoride and Chloride
ISE Assays with Fluoride Selectivity Factors (SF), from Hill
Analyses
EC50, μM (mol%)
a
receptor F− Cl− SF
b
1 −c −c −c
2 13 (1.3) 24 (2.4) 1.8
3 9 (0.9) 16 (1.6) 1.8
4 12 (1.2) 5 (0.5) 0.4
aEC50 at 270 s of receptor with respect to lipid.
bFluoride selectivity
determined from EC50 for chloride transport divided by EC50 for
ﬂuoride transport. SF > 1 indicates ﬂuoride selectivity.
cNo transport
ability in this assay; no Hill analysis results or selectivity factors.
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chloride (NMDG-Cl, 100 mM) and suspended in NMDG-Cl
(100 mM).10 All solutions were buﬀered to pH 7.0 with HEPES
(10 mM). The anionophore was added, followed by a base pulse
(NMDG 5 mM) to generate a pH gradient, and the dissipation
of this gradient by the anionophore was monitored by following
the HPTS ﬂuorescence ratio. This assay measures the receptor’s
electroneutral H+/Cl− co-transport (Cl−/OH− antiport) ability. If
the receptor functions as a selective electrogenic Cl− transporter,
as found for 2−4, the H+/OH− transport will be the rate-limiting
factor for transport. Addition of the proton channel Gra should
accelerate the H+ transport, removing this rate-limiting eﬀect.
Quantiﬁcation of the transport in both cases (with and
without the proton channel) permits selectivity for chloride over
proton or hydroxide transport to be calculated. Addition of oleic
acid allows evaluation of the chloride selectivity of the receptors
over the ability to contribute to the naturally occurring fatty
acid proton transport pathway by assisting ﬂip-ﬂop of fatty acid
anions described in Figure 5a,b. Figure 5a shows how a receptor
capable of complexation to the deprotonated headgroup of a
fatty acid can artiﬁcially enhance the natural proton shuttling
seen with fatty acids in nature.59,60 Receptor masking of the
charged headgroup accelerates movement of the charged form of
the headgroup across the membrane. Figure 5b(iii) shows this
eﬀect within the NMDG assay, with overall H+/Cl− symport
being observed. Experimentally, this eﬀect can artiﬁcially
accelerate the pH gradient dissipation with the fatty acid
ﬂip-ﬂop process, hence, the Cl− > H+/OH− selectivity will
decrease in the presence of fatty acids within a membrane if the
receptor has some aﬃnity for the fatty acid headgroup. Since the
presence of free (unesteriﬁed) fatty acids is ubiquitous in cel-
lular membranes, this is important/undesirable in our ongoing
eﬀort in the development of Cl− > H+/OH−-selective synthetic
anionophores for potential therapeutic application against cystic
ﬁbrosis.50,51
Dose−response experiments and Hill analyses were per-
formed in the absence and presence of gramicidin and oleic
acid to gain EC50 values. The ratio of these EC50 values was
Figure 4. Overview of the osmotic assay results for 3 and 4. All assays
were performed with POPC LUVs (400 nm) loaded with KF or KOAc
(300 mM) and suspended in KGlc (300 mM) at pH 7.2, and the anion
eﬄux was measured indirectly by light scattering intensity. Top:
(a) light scattering result caused by the eﬄux of ﬂuoride facilitated by
3 and 4 and consequent dehydration of the vesicle. Bottom: (b) light
scattering result caused by the eﬄux of acetate facilitated by 3 and 4
and consequent dehydration of the vesicle.
Figure 5. Mechanism of fatty acid movement and proton transport across lipid bilayers, enhanced by an anion receptor and consequently increasing
the HPTS response in the NMDG assay by accelerating the dissipation of the pH gradient. (a) Oleic acid molecules within the membrane bound to
a proton undergo a ﬂip-ﬂop across the membrane from the pH 7 interior to the pH 8 exterior. These protons are deposited, causing a change in the
pH gradient across the membrane. A receptor can then bind and transport the deprotonated acid headgroup back to the interior to complete the
cycle, resulting in the dissipation of pH gradient.59,60 (b)-(i) Schematic to show the natural function of the oleic acid ﬂip-ﬂop with the slow, rate-
determining step. (ii) Schematic to show how a receptor can complex the deprotonated acid headgroup to accelerate the rate-determining step by
masking the charge on the headgroup. (iii) Schematic to show this process in relation to the NMDG assay, causing Cl−/OA− antiport and overall
H+/Cl− symport facilitated by a receptor and oleic acid, thus artiﬁcially increasing the pH dissipation rate.
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used to quantify the chloride selectivity, giving selectivity
factors (SG and SOA/G) presented in Table 3. It is important
to note that these selectivity factors are relative to the Cl−
concentration used within the assay.51 Receptors 2−4 show
good selectivity for chloride along the series, with an SG of 18.2,
10.3, and 13.5, respectively; 2, the shortest strapped, smallest
cavity receptor possessed the highest selectivity for chloride,
which supports previous ﬁndings that a higher degree of anion
encapsulation enforces a higher degree of anion desolvation and
hence better selectivity for chloride transport.51 Figure 6 shows
the EC50 values in a bar chart to help visualize this selectivity.
In the presence of oleic acid, the eﬀect of artiﬁcially enhanced
H+/Cl− symport due to the fatty acid ﬂip-ﬂop side process is
negligible in 2 and 3; however, there is a mild increase in the
transport ability of 4 by a factor of 1.7. This result correlates
to the ﬁndings in the osmotic assay and ITC study that 4 is
likely to bind and transport acetate, as it is more inclined to
bind the oxoanionic oleic acid headgroup (Figure 5) to enhance
its proton shuttle eﬀect and therefore accelerate the dissipation
of the pH gradient.63 This resulted in a loss of Cl− > H+/OH−
selectivity (SOA/G) for 4 by a diﬀerence of 5.5; while there is a
small loss for 3, the selectivity of the shortest strapped 2 was
not compromised in the presence of fatty acid. These results
reiterated the advantageous eﬀect of encapsulation and enforced
steric hindrance in the design of synthetic anion transporters for
overall Cl− > H+/OH− selectivity.
■ CONCLUSIONS
Using a ﬂuoride ion-selective electrode assay, we have shown
the ﬁrst example of a direct measurement of small synthetic
molecule facilitated, transmembrane ﬂuoride transport via an
electrogenic anion transport mechanism, mimicking an impor-
tant natural transport process that occurs in bacteria. The shorter
strapped receptors 2 and 3 are moderately selective for ﬂuoride
over chloride in the Vln coupled assay. Additionally, we have
quantiﬁed the Cl− > H+/OH− selectivity of 2−4, ﬁnding them
highly selective for Cl− over H+/OH−, which supports previous
ﬁndings that encapsulation is the key to selectivity.51 We also
evaluated how the presence of a naturally occurring fatty
acid interferes with the receptor’s transport mechanism and
compromises the overall Cl− > H+/OH− selectivity, conﬁrming
the need for consideration of fatty acid aﬃnity when designing
transporters for physiological purposes. Remarkably, the shortest
strapped calixpyrrole 2 not only demonstrated the best Cl− >
H+/OH− selectivity but also fully maintained the selectivity in
the presence of fatty acid. These results illustrate the importance
of encapsulation and point the way forward in the design of
halide-selective transporters.
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selectivity value SG is calculated by dividing EC50 in the absence of Gra by the EC50 Gra. SG > 1 indicates Cl
− selectivity. cEC50 in the presence of
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Figure 6. Bar chart of EC50 results for 2−4 from POPC LUVs (200
nm) loaded with NMDG-Cl (100 mM) and HPTS (1 mM)
suspended in NMDG-Cl (100 mM). The H+/Cl− symport (or
OH−/Cl− antiport) dose−response of 2−4 was measured by mon-
itoring the HPTS ﬂuorescence ratio after the addition of a 5 mM
NMDG pulse (with an additional pulse of gramicidin D (0.1 μM,
0.1 mol%) or oleic acid (2 μM, 2 mol%) as appropriate). The Hill
equation was used to ﬁt the dose−response curves for 2−4 alone, with
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Hill equation can be found in the Supporting Information.
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